Siripipattanamongkol, C., Srinarong, C., & Asa, P. (2019). Effectiveness and safety of Pegylated-Interferon/Ribavirin and direct acting antiretroviral: DAA treatment in chronic hepatitis C in Chiangrai Prachanukroh hospital. เชียงรายเวชสาร, 11(1), 41–54. สืบค้น จาก https://he01.tci-thaijo.org/index.php/crmjournal/article/view/185641